Use of Atypical Antipsychotic Agents in Bipolar and Schizoaffective Disorders
- 1 August 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 19 (4) , 354-361
- https://doi.org/10.1097/00004714-199908000-00012
Abstract
Atypical antipsychotic agents seem to be effective treatments for bipolar disorder, especially as adjunctive treatments. They may be a safer and more effective alternative to the common practice of maintenance adjunctive treatment with traditional antipsychotic agents in patients with bipolar disorder. However, currently available research studies are limited methodologically mainly to open-label, uncontrolled designs. Further research is required before the definitive efficacy of these agents in bipolar disorder is established. If randomized or double-blind data support the open-label data reviewed here, atypical antipsychotic agents may possess an important role in the adjunctive treatment of bipolar disorder.Keywords
This publication has 34 references indexed in Scilit:
- Treatment of manic episodes: Zuclopenthixol and Clonazepam versus Lithiim and ClonazepamActa Psychiatrica Scandinavica, 1996
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study GroupPublished by American Medical Association (AMA) ,1994
- Neuroleptic exposure following inpatient treatment of acute mania with lithium and neurolepticAmerican Journal of Psychiatry, 1994
- Prospective study of tardive dyskinesia incidence in the elderlyPublished by American Medical Association (AMA) ,1991
- Adjunctive Clonazepam for Maintenance Treatment of Bipolar Affective DisorderJournal of Clinical Psychopharmacology, 1990
- Comparison of the Prophylactic Action of Flupenthixol with Placebo in Lithium Treated Manic-Depressive PatientsThe British Journal of Psychiatry, 1986
- Tardive DyskinesiaAnnual Review of Medicine, 1984
- Flupenthixol decanoate in recurrent manic‐depressive illnessActa Psychiatrica Scandinavica, 1981
- Course of the Manic-Depressive Cycle and Changes Caused by TreatmentsPharmacopsychiatry, 1980
- A Double-Blind Comparison of Lithium Carbonate and Maprotiline in the Prophylaxis of the Affective DisordersThe British Journal of Psychiatry, 1976